Pressemitteilung vom 08.06.2020 Nachricht vom 08.06.2020


EURD-List Rev. 92

  • acitretin
  • alglucosidase alfa
  • ambroxol
  • ambroxol / clenbuterol
  • aminosalicylic acid
  • anagrelide
  • arsenic trioxide
  • artemether / lumefantrin (apart from the dispersible tablet)
  • atenolol / chlortalidone
  • bexarotene
  • bromazepam
  • bromhexine
  • buprenorphine (other formulations except for implant)
  • cabazitaxel
  • carbidopa / levodopa
  • chloroquine
  • chlorpromazine
  • clenbuterol
  • clofarabine
  • conestat alfa
  • deferasirox
  • deferiprone
  • degarelix
  • dexrazoxane
  • dinoprostone
  • docetaxel
  • eculizumab
  • emedastine
  • epoetin alpha
  • epoetin theta
  • fentanyl (transmucosal route of administration)
  • fingolimod
  • fludeoxyglucose (18F)
  • fluoxetine
  • hexaminolevulinate hydrochloride
  • human hemin
  • human papillomavirus vaccine (rDNA) - 4-valent
  • hydroxychloroquine
  • hydroxyzine chloride / hydroxyzine pamoate and all fixed combination, hydroxyzine
  • 'ioflupane (123i)
  • irinotecan (except for liposomal formulations)
  • ketobemidone
  • laronidase
  • lenalidomide
  • lenograstim
  • letrozole
  • levosimendan
  • caffeine / drotaverine hydrochloride / metamizol sodium
  • methotrexate
  • methylphenidate
  • milnacipran
  • buprenorphine / naloxone
  • oxaliplatin
  • paracetamol / tramadol
  • paracetamol (IV formulation)
  • pazopanib
  • pemetrexed
  • posaconazole
  • pramiracetam
  • ranibizumab
  • rivastigmine
  • ropinirole
  • rufinamide
  • sulfur hexafluoride
  • sumatriptan
  • tafamidis
  • technetium (99mTc) bicisate
  • thalidomide
  • thiotepa (centrally authorised product only)
  • tiagabine
  • tianeptine
  • tiapride
  • tigecycline
  • toremifene
  • verteporfin
  • zopiclone, eszopiclone
  • dorzolamide
  • decitabine
  • pasireotide
  • perampanel
  • chlorquinaldol (vaginal tablet) / promestriene
  • vandetanib
  • pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
  • ceftaroline fosamil
  • aflibercept (ophthalmological indication(s))
  • catridecacog
  • crizotinib
  • glycopyrronium bromide (for centrally authorised product indicated for chronic obstructive pulmonary disease)
  • betamethasone / tetryzoline
  • defibrotide
  • granisetron (transdermal patch)
  • midazolam (oromucosal solution, treatment of prolonged, acute, convulsive seizures)
  • ocriplasmin
  • turoctocog alfa
  • felbamate
  • cilostazol
  • delamanid
  • drospirenone / ethinylestradiol
  • hydroxocobalamin (only for products for chemical poisoning)
  • everolimus (indicated for rejection of transplanted organs)
  • obinutuzumab
  • nintedanib (oncology indications)
  • nintedanib (respiratory indication)
  • carmustine (implant)
  • carmustine (powder and solvent for solution for infusion)
  • ceritinib
  • edoxaban
  • 1-propanol / 2-propanol / lactic acid
  • idarucizumab
  • talimogene laherparepvec
  • dexamethasone (centrally authorised product indicated in symptomatic multiple myeloma)
  • irinotecan (liposomal formulations)
  • bezlotoxumab
  • chlormethine
  • parathyroid hormone
  • cerliponase alfa
  • meningococcal group B vaccine (recombinant, adsorbed)
  • sodium oxybate (oral use)
  • patiromer
  • midostaurin
  • opium
  • herpes zoster vaccine (recombinant, adjuvanted)
  • allergen for therapy: Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)
  • axicabtagene ciloleucel
  • durvalumab
  • brigatinib
  • valsartan / rosuvastatin
  • glycopyrronium bromide / formoterol
  • voretigene neparvovec
  • apalutamide
  • andexanet alfa
  • sotagliflozin
  • talazoparib
  • thiamine / riboflavin/ pyridoxine / ascorbic acid / nicotinamide/ glucose, thiamine /riboflavin / pyridoxine / ascorbic acid / nicotinamide, ascorbic acid / biotin / cyanocobalamin / folic acid / nicotinamide / pantothenic acid / pyridoxine hydrochloride / riboflavin / thiamine
  • remdesivir
  • dronabinol/cannabidiol
  • calcium carbonate / sodium alginate / sodium bicarbonate, sodium alginate / sodium bicarbonate, sodium alginate/ potassium hydrogen carbonate, sodium alginate/magnesium alginate
  • 13C-methacetin
  • lidocaine hydrochloride / neomycin sulfate / polymyxin b, lidocaine hydrochloride monohydrate / fludrocortisone acetate / neomycin sulfate / polymyxin b
  • onasemnogene abeparvovec
  • cefiderocol
Zurück zur Übersicht

Rechtliche Hinweise

Der BPI Wirkstoff-Alert wird mit größter Sorgfalt zusammengestellt.
Der BPI e.V. haftet jedoch nicht für Unrichtigkeiten oder Unvollständigkeiten im Zusammenhang mit den bereitgestellten Inhalten. Dies gilt im Besonderen auch für eigene unternehmerische Entscheidungen, die auf Grundlage der Informationen des BPI Wirkstoff-Alerts getroffen werden.